Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Bristol Myers Squibb - Navigating the Integration of Immuno-Oncology Into the Perioperative Muscle-Invasive Urothelial Carcinoma Treatment Landscape

Interactive Multidisciplinary Team Meeting

Date

12 Sep 2022

Session

Bristol Myers Squibb - Navigating the Integration of Immuno-Oncology Into the Perioperative Muscle-Invasive Urothelial Carcinoma Treatment Landscape

Topics

Tumour Site

Genitourinary Cancers

Presenters

Margitta Retz

Authors

A. Necchi1, M. Roupret2, M. Retz3

Author affiliations

  • 1 Medical Oncology Dept., IRCCS Ospedale San Raffaele, 20132 - Milan/IT
  • 2 Sorbonne Université - Site Saint-Antoine, 75012 - Paris, Cedex 12/FR
  • 3 Bristol-Myers Squibb GmbH&Co. KGaA, 80636 - Munich/DE

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.